Ehrlich Christopher B

10% owner at ANESIVA, INC. · on record since Mar 31, 2006
Director at BIOMIMETIC THERAPEUTICS, INC. · on record since May 16, 2006
Director at Launch One Acquisition Corp. · on record since Jul 11, 2024
Chief Executive Officer at Launch One Acquisition Corp. · on record since Jul 11, 2024
Chairman and CEO at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 5, 2021
10% owner at ReShape Weightloss Inc. · on record since Nov 21, 2007
Director at Paratek Pharmaceuticals, Inc. · on record since Feb 3, 2009
Venture Member at Trius Therapeutics Inc · on record since Aug 10, 2010
10% owner at Paratek Pharmaceuticals, Inc. · on record since Sep 22, 2011
10% owner at TESARO, Inc. · on record since Jun 27, 2012
10% owner at INTRALASE CORP · on record since Oct 6, 2004
Director at eFFECTOR Therapeutics, Inc. · on record since Jan 14, 2021
Chief Executive Officer at eFFECTOR Therapeutics, Inc. · on record since Jan 7, 2021
10% owner at eFFECTOR Therapeutics, Inc. · on record since Jan 7, 2021
Director at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 12, 2021
10% owner at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 12, 2021
10% owner at MYOGEN INC · on record since Jun 30, 2005

Insider trading activity of Ehrlich Christopher B

Transactions on record: 74; since Mar 1, 2006

Open-market buys: 14; $13.1M

Open-market sells: 0

Companies traded: 5; last filing Jan 9, 2026

Figures computed from official regulatory filings — .

Companies where Ehrlich Christopher B has traded

23 tx · $4M · Jan 9, 2026
22 tx · $90.7K · Jun 13, 2024
10 tx · $5M · Apr 11, 2013
15 tx · $8M · Mar 5, 2013
4 tx · $19.8K · Mar 1, 2006

Track record of Ehrlich Christopher B

Statistical track record

Free account

Open-market buys: 14

Last buy: Oct 4, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Ehrlich Christopher B

Co-insiders of Ehrlich Christopher B

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Jan 9, 2026	AwardD (derivative)	4,530,997	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Jun 2, 2025	AwardD (derivative)	61,843	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Mar 6, 2025	AwardD (derivative)	119,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 26, 2025	AwardD (derivative)	1,275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Dec 4, 2024	AwardD (derivative)	1,275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	OtherD (derivative)	-572,182	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	Exercise	5,312,983	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	ExerciseD (derivative)	-275	1,000.00 USD	$275K		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Mar 27, 2024	AwardD (derivative)	572,182	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Feb 21, 2024	AwardD (derivative)	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	-349,998	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	ExerciseD (derivative)	1,555	1,000.00 USD	$1.6M		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	-1,555	1,000.00 USD	$1.6M	Unusual size	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	-4,171,246	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	478,825	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	AwardD (derivative)	100	1,000.00 USD	$100K		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	175	1,000.00 USD	$175K		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	ExerciseD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	-1,125,000	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	3,600	—	n/a (No price was disclosed in the filing)		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jun 22, 2023	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jan 24, 2023	AwardD (derivative)	35,938	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Oct 6, 2022	Buy	346	0.57 USD	$197.2	conv 20	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Jan 9, 2026	AwardD (derivative)	4,530,997	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Jun 2, 2025	AwardD (derivative)	61,843	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Mar 6, 2025	AwardD (derivative)	119,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 26, 2025	AwardD (derivative)	1,275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Dec 4, 2024	AwardD (derivative)	1,275,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	OtherD (derivative)	-572,182	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	Exercise	5,312,983	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 2, 2024	ExerciseD (derivative)	-275	1,000.00 USD	$275K		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Mar 27, 2024	AwardD (derivative)	572,182	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Feb 21, 2024	AwardD (derivative)	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	-349,998	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	ExerciseD (derivative)	1,555	1,000.00 USD	$1.6M		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	-1,555	1,000.00 USD	$1.6M	Unusual size	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	-4,171,246	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	478,825	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	AwardD (derivative)	100	1,000.00 USD	$100K		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	175	1,000.00 USD	$175K		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	ExerciseD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	OtherD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	-1,125,000	—	n/a (No price was disclosed in the filing)		SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	3,600	—	n/a (No price was disclosed in the filing)		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jun 22, 2023	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Jan 24, 2023	AwardD (derivative)	35,938	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
eFFECTOR Therapeutics, Inc.Listing on record	Oct 6, 2022	Buy	346	0.57 USD	$197.2	conv 20	SEC